November 19, 2019 / 12:31 PM / 25 days ago

BRIEF-Newron Receives FDA Rare Pediatric Disease Designation For Sarizotan

Nov 19 (Reuters) - Newron Pharmaceuticals SpA:

* NEWRON RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR SARIZOTAN FOR THE TREATMENT OF RETT SYNDROME Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below